Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 30.04.2024
Relief Therapeutics Holding SA
Relief Therapeutics has published its Annual Report
GENEVA (APR. 30, 2024) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today published its Annual Report 2023 and provided a corporate update. [ … ]
Tue, 30.04.2024
SURTECO GROUP SE
SURTECO GROUP SE: Good start to the year 2024
EBITDA at € 27.6 million up by 44 % compared with previous year
Consolidated net profit increases by 90 % to € 6.9 million
Buttenwiesen, 30 April 2024 – In the first quarter of 2024, sales of the SURTECO Group at € 222.3 million were 8 % above the year-earlier value of € 205.7 million. The acquired di [ … ]
Tue, 30.04.2024
Nemetschek SE
Corporate News
Nemetschek Group: Successful start to the year in Q1 2024 with double-digit operational revenue growth at a continued high profitability level
+68.0% growth (currency-adjusted) in subscription & SaaS to EUR 106.3 million
+25.4% ARR growth (currency-adjusted) to EUR 743.6 million
+10.3% revenue growth (currency-adjusted) to EU [ … ]
Tue, 30.04.2024
SIG Group AG
Media Release
April 30, 2024
Q1 2024 trading update
Stable volumes, initial signs of growth recovery, progress on production footprint
Q1 2024 revenue, at constant currency, in line with strong prior year (constant currency and constant resin[1] also in line with prior year)
Q1 2024 reported revenue declined by 1.0% compared with Q1 2023
Volume [ … ]
Tue, 30.04.2024
Branicks Group AG
Branicks Group AG: Operationally successful in a challenging 2023 financial year
Press release
Branicks Group AG: Operationally successful in a challenging 2023 financial year
Targets for 2023 largely achieved
Financing secured
Many new lettings continue at good conditions
New renewables asset class
Branicks Group AG (Branicks), ISIN: [ … ]
Tue, 30.04.2024
FUCHS SE
FUCHS with good start into financial year 2024
Decrease in sales revenues of 6% to EUR 877 million due to price adjustments and
negative currency effects
EBIT improved by 4% or EUR 4 million to EUR 107 million
Full-year outlook 2024 confirmed
Agreement signed on the acquisition of the international LUBCON Group
FUCHS at a glance
in EUR milli [ … ]
Tue, 30.04.2024
DocMorris AG
Please find our press release under the following link:https://ir-corporate.docmorris.com/en/investor-relations/convertible-bonds-2024
End of Inside Information
Language:
English
Company:
DocMorris AG
Walzmühlestrasse 49
8500 Frauenfeld
Switzerland
ISIN:
CH0042615283
Listed:
SIX Swiss Exchange
EQS News ID:
1892265
End of Announceme [ … ]
Tue, 30.04.2024
ALSO Holding AG
Emmen, Switzerland, 30 April 2024
PRESS RELEASE
Ad hoc announcement pursuant to Art. 53 KR
ALSO finalises succession planning:Wolfgang Krainz appointed as new CEO
As of 1 May 2024, he will succeed Gustavo Möller-Hergt, who continues to serve as President of the Board of Directors of ALSO Holding AG (SIX: ALSN).
Wolfgang Krainz ha [ … ]
Tue, 30.04.2024
Newron Pharmaceuticals S.p.A.
Newron announces positive top-line results
from potentially pivotal Phase II/III study 008A with evenamide in schizophrenia patients
Primary endpoint and key secondary endpoint of study met; drug was well tolerated, with no safety concerns identified
Glutamatergic inhibition mechanism of action offers an innovative therapeutic option to schizoph [ … ]
Tue, 30.04.2024
Baloise Holding AG
Basel, 30 April 2024. Baloise has disclosed a healthy solvency ratio of 207 per cent in the Group’s latest financial condition report.
Baloise has published its financial condition report, which includes details of its solvency ratio calculated in accordance with the conditions of the Swiss Solvency Test (SST). The relevant date for the calculation [ … ]